Delivery Order SPE2DX22D0010-SPE2D826FCJ47
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,985.64 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30 mg) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,377.52 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (5mg) on November 28, 2025, with a completion deadline of December 1, 2025. This competitive, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,325.97 for 100 tablets of Adderall 30mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Adderall 30mg tablets (100-count packages) under a firm fixed-price contract valued at $1,225.66. The contract, which is a non-set-aside competitive award, calls for ultimate completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Adderall 10 mg tablets. The total potential value of this delivery order is $4,995.25, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall tablets (10mg) under a firm fixed-price contract with a ceiling value of $9,584.53. This non-set-aside award represents a competitively awarded delivery order with an ultimate completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,022.50 contract is to provide 4,563,977,383 units of ADDERALL 30MG TAB 100S to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,165,184 units of Adderall 30 mg tablets. The $2,126.53 contract has a completion date of December 22, 2023. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contracts from the Defense Logistics Agency to provide pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency awarded a $1,225.66 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of December 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order worth $1,533.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,472,975 tablets of 30mg Adderall. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is part of a larger indefinite...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCJ47Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,930.88 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30mg) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen). This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program, valued at up to $999,999,999.00 through December 2026. This comprehensive contract enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The IDC serves the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems, demonstrating the contractor's capability to efficiently fulfill essential pharmaceutical requirements for military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/11/26 |